{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:51:51Z","timestamp":1790315511884,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.vaccine.2017.09.038","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T06:45:37Z","timestamp":1506667537000},"page":"6187-6194","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo"],"prefix":"10.1016","volume":"35","author":[{"given":"Reena H.","family":"Doshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Eckhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mukadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calixte","family":"Shidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile Okitolonda","family":"Wemakoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Muyembe-Tafum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F.","family":"Kominski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W.","family":"Rimoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.09.038_b0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF01253787","article-title":"The public health problem created by measles in the developing countries","volume":"16","author":"Morely","year":"1965","journal-title":"Arch ges Virusforsch"},{"key":"10.1016\/j.vaccine.2017.09.038_b0010","unstructured":"World Health Organization, Measles Fact Sheet No. 286. 2014."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.09.038_b0015","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.1093\/infdis\/jir129","article-title":"Changing epidemiology of measles in Africa","volume":"204","author":"Goodson","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.038_b0020","unstructured":"Verguet S, et al. The broader economic benefits of measles supplemental immunization as a delivery platform for other childhood interventions in India. 2011: University of Washington."},{"issue":"44","key":"10.1016\/j.vaccine.2017.09.038_b0025","first-page":"421","article-title":"Global Routine Immunization Coverage 2011","volume":"87","author":"Organization","year":"2012","journal-title":"Weekly Epidemiologic Record"},{"key":"10.1016\/j.vaccine.2017.09.038_b0030","unstructured":"Programme Elargi De Vaccination, Plan Strat\u00e9gique d'\u00e9limination de la Rougeole en RDC: 2012-2020. 2012: Democratic Republic of Congo."},{"key":"10.1016\/j.vaccine.2017.09.038_b0035","unstructured":"Measure DHS ICF International, Republique Democratique du Congo Enquete Demographique et de Sante 2013-2014: Report preliminaire. 2014."},{"key":"10.1016\/j.vaccine.2017.09.038_b0040","unstructured":"World Health Organization, Revised WHO position on measles vaccine 2009. Weekly epidemiological record, 2009."},{"key":"10.1016\/j.vaccine.2017.09.038_b0045","unstructured":"World Health Organization, Democratic Republic of the Congo: WHO and UNICEF Esimates of immunization coverage: 2015 ed. 2015."},{"key":"10.1016\/j.vaccine.2017.09.038_b0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.inhe.2009.12.009","article-title":"Reactive vaccination as an effective tool for measles outbreak control in measles mortality reduction settings, Democratic Republic of Congo, 2005\u20132006","volume":"2","author":"Alberti","year":"2011","journal-title":"International Health"},{"key":"10.1016\/j.vaccine.2017.09.038_b0055","unstructured":"World Health Organization, Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. 2003: Geneva."},{"key":"10.1016\/j.vaccine.2017.09.038_b0060","unstructured":"Global Alliance for Vaccines and Immunization. Democratic Republic of Congo: GAVI Factsheet. 2014; Available from: http:\/\/www.gavi.org\/country\/drc\/."},{"issue":"232","key":"10.1016\/j.vaccine.2017.09.038_b0065","first-page":"6","article-title":"Measles in Democratic Republic of Congo: an outbreak description from Katanga, 2010\u20132011","volume":"13","author":"Grout","year":"2013","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.vaccine.2017.09.038_b0070","first-page":"8","volume":"39","author":"Sudfield","year":"2010","journal-title":"Effectiveness of Measles vaccination and vitamin A treatment."},{"key":"10.1016\/j.vaccine.2017.09.038_b0075","first-page":"8","article-title":"Measles outbreak in Burkina Faso, 2009: A case-control study to determine risk factors and estimate vaccine effectiveness","volume":"30","author":"Kidd","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.09.038_b0080","doi-asserted-by":"crossref","unstructured":"Plotkin S, Orenstein W. Vaccines. 3rd ed. 1999.","DOI":"10.1097\/00024382-199910000-00017"},{"issue":"1","key":"10.1016\/j.vaccine.2017.09.038_b0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/1045-1056(95)90018-7","article-title":"The effect of dose and strain of live attenuated measles vaccines on serological responses in young infants","volume":"23","author":"Cutts","year":"1995","journal-title":"Biologicals"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2017.09.038_b0090","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.vaccine.2003.07.007","article-title":"Cost-effectiveness of three different vaccination strategies against measles in Zambian children","volume":"22","author":"Dayan","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.09.038_b0095","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/ije\/17.2.448","article-title":"Immunogenicity and safety of measles vaccine in ill African children","volume":"17","author":"Ndikuyeze","year":"1988","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2017.09.038_b0100","series-title":"Minister of Public Health, and ICF International, Demographic and Health Survey, Democratic Republic of Congo 2013\u20132014","author":"Minister of Plan","year":"2014"},{"key":"10.1016\/j.vaccine.2017.09.038_b0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1752-1505-8-9","article-title":"Description of a large measles epidemic in Democratic Republic of Congo, 2010\u20132013","volume":"8","author":"Mancini","year":"2014","journal-title":"Confl Health"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.09.038_b0110","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1093\/infdis\/jir096","article-title":"Global eradication of measles: an epidemiologic and economic evaluation","volume":"204","author":"Levin","year":"2011","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.09.038_b0115","first-page":"205","article-title":"The benefits from 10 years of measles immunization in the United States","volume":"90","author":"Witte","year":"1975","journal-title":"Public Health Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2017.09.038_b0120","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/infdis\/144.5.486","article-title":"Cost-effectiveness and cost-benefit analyses of vaccines","volume":"144","author":"Willems","year":"1981","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.09.038_b0125","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1093\/infdis\/jir114","article-title":"Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination","volume":"204","author":"Garrison","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.038_b0130","unstructured":"United Nations Children's Fund, Multiple Indicator Cluster Survey (MICS-2010), Preliminary Report, Democratic Republic of Congo. 2010."},{"issue":"37","key":"10.1016\/j.vaccine.2017.09.038_b0135","first-page":"1036","article-title":"Progress toward measles control - African region, 2001\u20132008","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"35","key":"10.1016\/j.vaccine.2017.09.038_b0140","first-page":"349","article-title":"Measles vaccines: WHO position paper","volume":"84","author":"World Health Organization","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.09.038_b0145","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1086\/377741","article-title":"Measles eradication in the Americas: progress to date","volume":"189","author":"de Quadros","year":"2004","journal-title":"J Infect Dis"},{"issue":"9317","key":"10.1016\/j.vaccine.2017.09.038_b0150","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(02)08517-3","article-title":"First 5 years of measles elimination in southern Africa: 1996\u20132000","volume":"359","author":"Biellik","year":"2002","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.09.038_b0155","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/368272","article-title":"Impact of alternative approaches to accelerated measles control: experience in the African region, 1996\u20132002","volume":"187","author":"Otten","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.09.038_b0160","unstructured":"World Health Organization and United Nations Children's Fund, Joint annual measles report 2009. strenghening immunization services through measles control. 2009, World Health Organization: Geneva."},{"key":"10.1016\/j.vaccine.2017.09.038_b0165","unstructured":"India; M.O.H.A.F.W.G.O., Measles catch-up campaign immunization campagin: Guildlines for planning and implementation. 2010."},{"key":"10.1016\/j.vaccine.2017.09.038_b0170","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2458-14-67","article-title":"Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts","volume":"14","author":"Gandhi","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2017.09.038_b0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2471\/BLT.13.123471","article-title":"Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case meningitis A vaccine in Chad","volume":"92","author":"Lydon","year":"2014","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2017.09.038_b0180","unstructured":"Medicins San Frontieres, Everyday Emergency: Silent Suffering in the Democratic Republic of Congo. 2014."},{"issue":"31","key":"10.1016\/j.vaccine.2017.09.038_b0185","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1016\/j.vaccine.2009.04.079","article-title":"Scheduling of measles vaccination in low-income countries: projections of a dynamic model","volume":"27","author":"Bauch","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17312677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17312677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T22:44:06Z","timestamp":1570142646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17312677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":37,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0264410X17312677"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}